People | February 10, 2025
Jagsonpal Pharmaceuticals appoints Sachin Jain as CFO
He has over 23 years of experience across sectors
He has over 23 years of experience across sectors
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
Jagsonpal Pharmaceuticals has reported total income of Rs. 76.34 crores during the period ended September 30, 2024
The company has seamlessly integrated the business acquired from Yash Pharma into Jagsonpal and are now confident of aligning the margins of the acquired business with that of Jagsonpal ahead of schedule
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.
Manish led SeQuent since 2014 and played a major role in transforming the company
Suvinys Developers will supply dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.
Subscribe To Our Newsletter & Stay Updated
